Compare BioNano Genomics Inc (BNGO) vs Godaddy Inc (GDDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Godaddy Inc — how do they compare? BioNano Genomics Inc trades at $1.18 (market cap $13.20M), while Godaddy Inc trades at $91.91 (market cap $12.06B). The key difference: Godaddy Inc is far larger — about 913.6× BioNano Genomics Inc's market cap, and Godaddy Inc is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | GDDY | |
|---|---|---|
Market Cap | $13.20M | $12.06B |
Sector | Health | Technology |
52-Week High | $4.92 | $169.40 |
52-Week Low | $1.09 | $75.07 |
Enterprise Value | $15.81M | $14.65B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bionano Genomics (BNGO) trades at $1.17, down 2.5% today, but maintains a bullish technical signal with strong moving average support. The company shows improving fundamentals with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable with a -109.95% net margin. Recent positive developments include debt retirement and growing adoption of optical genome mapping technology.
BNGO presents a high-risk, high-reward opportunity with analyst consensus leaning bullish (57% buy ratings). The stock trades at attractive valuation multiples (P/S 0.31, P/B 0.36) but faces execution risks in achieving profitability. Key catalysts include continued technology adoption and potential margin improvement, while persistent losses and competitive pressures remain concerns.
GoDaddy (GDDY) trades at $90.86, up 2.18% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The company shows robust fundamentals, including a 17.32% net income margin and a P/E of 14.4, while analyst consensus is a Buy with a $123 price target. However, recent news highlights a securities class action investigation, adding a layer of risk.
The outlook remains positive due to consistent earnings performance and solid cash flow, but investors should weigh the legal overhang and high debt levels against the stock's growth potential and attractive valuation multiples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Godaddy Inc
GoDaddy is a provider of domain registration and aftermarket services, website hosting, security, design, and business productivity tools, commerce solutions, and domain registry services. The company primarily targets micro- to small businesses, website design professionals, registrar peers, and domain investors. Since acquiring payment processing platform Poynt in 2021, the company has expanded into omnicommerce solutions, including offering an online payment gateway and offline point-of-sale devices.
Read more on GDDY →
